Trials / Completed
CompletedNCT00644735
Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed
Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 750 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A study to look at the rates of remission (non re-appearance of erosive esomeprazole) when treated with esomeprazole or lansoprazole; in patients in with erosive esomeprazole (EE) that is in remission (i.e. previously healed EE).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole | |
| DRUG | Lansoprazole |
Timeline
- Start date
- 2002-12-01
- Primary completion
- 2004-01-01
- Completion
- 2004-01-01
- First posted
- 2008-03-27
- Last updated
- 2009-03-26
Source: ClinicalTrials.gov record NCT00644735. Inclusion in this directory is not an endorsement.